Legal & General Group Plc Lowers Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Legal & General Group Plc trimmed its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 6.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 423,490 shares of the medical instruments supplier's stock after selling 26,846 shares during the quarter. Legal & General Group Plc owned 0.21% of DENTSPLY SIRONA worth $8,038,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in DENTSPLY SIRONA by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after purchasing an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC raised its stake in DENTSPLY SIRONA by 2.5% in the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after buying an additional 348,532 shares during the last quarter. Nuance Investments LLC boosted its holdings in DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after acquiring an additional 2,708,097 shares in the last quarter. Cooke & Bieler LP grew its stake in shares of DENTSPLY SIRONA by 24.3% during the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock worth $174,101,000 after acquiring an additional 1,794,391 shares during the last quarter. Finally, Pacer Advisors Inc. increased its holdings in shares of DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after acquiring an additional 4,473,972 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction dated Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.52% of the company's stock.

Analyst Upgrades and Downgrades

XRAY has been the topic of several research analyst reports. Evercore ISI reissued an "in-line" rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Mizuho reduced their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Finally, Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research note on Tuesday. Thirteen analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Hold" and a consensus target price of $22.58.

DENTSPLY SIRONA Trading Up 1.4 %

Shares of DENTSPLY SIRONA stock opened at $12.83 on Friday. The firm has a 50-day simple moving average of $15.72 and a two-hundred day simple moving average of $18.82. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $31.00. The company has a market cap of $2.56 billion, a P/E ratio of -6.20, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.99%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.